谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial

Matthew J Matasar,Marcelo Capra,Muhit Özcan,Fangfang Lv,Wei Li,Eduardo Yañez,Katya Sapunarova,Tongyu Lin,Jie Jin,Wojciech Jurczak,Aryan Hamed,Ming-Chung Wang,Ross Baker,Igor Bondarenko,Qingyuan Zhang,Jifeng Feng,Klaus Geissler,Mihaela Lazaroiu,Guray Saydam,Árpád Szomor

The Lancet Oncology（2021）

引用 0|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要